Wolverine Trading’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History
Bought
Maintained
Sold
Other funds holding LABD
IC
BFM
TRCT
VF
TSS
SRL
Wolverine Trading's LABD Position: Q3 2023 in Review
Wolverine Trading sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2023, closing a stake of 1,225 shares — an estimated $199K sold.
Wolverine Trading first reported a position in LABD in Q4 2019 and held it in 9 quarters. The position peaked at $910K in Q1 2020. 16 funds tracked by Wall St. Rank hold LABD as of Q3 2023.
- Wolverine Trading reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q3 2023 after selling out during the quarter.
- Wolverine Trading sold 1,225 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2023, an estimated $199K.
- Wolverine Trading first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2019 and held it in 9 quarters.
- Wolverine Trading's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $910K in Q1 2020.
- 16 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2023.
Based on Wolverine Trading's 13F filing for Q3 2023, filed 15 Nov 2023.